Zelquistinel

N/A

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameZelquistinel
Drug Alias NameAGN-241751GATE-251
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor modulators
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaIND
Originator CompaniesAptinyx Inc
China Registration ClassN/A

Develop Information

Active CompaniesSyndeio Biosciences IncNorchim SasNaurex Inc +[5] 
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Major
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A